Oramed Pharmaceuticals
ORMP
#8952
Rank
C$0.21 B
Marketcap
C$5.26
Share price
0.26%
Change (1 day)
64.94%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): C$80.13 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are C$2 Million. In 2024 the company made an earning of -C$20.6 Million a decrease over its 2023 earnings that were of C$9.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$80.13 M-489.11%
2024 -C$20.6 Million-311.47%
2023 C$9.73 M-119.45%
2022 -C$50.07 Million39.17%
2021 -C$35.98 Million73.93%
2020 -C$20.69 Million18.53%
2019 -C$17.45 Million-16.62%
2018 -C$20.93 Million38.32%
2017 -C$15.13 Million12.51%
2016 -C$13.45 Million25.01%
2015 -C$10.76 Million18.18%
2014 -C$9.11 Million39.72%
2013 -C$6.52 Million46.4%
2012 -C$4.45 Million128.32%
2011 -C$1.95 Million-51.47%
2010 -C$4.02 Million35.21%
2009 -C$2.98 Million
2007 -C$4.68 Million607.04%
2006 -C$0.67 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
C$28.65 B 35,853.48%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$10.52 B 13,105.89%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-C$0.7 Billion-973.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-C$93.74 Million-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-C$37.68 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel